Table 4 Outcome-related indicators of study participants with and without MetS by sex groups
Characteristics | Males (N = 2297) | P | Females (N = 3182) | P | ||
|---|---|---|---|---|---|---|
MetS M(P25-P75) | Non-MetS M(P25-P75) | MetS M(P25-P75) | Non-MetS M(P25-P75) | |||
WC (cm) | 83.000 (77.000–87.600) | 96.000 (90.00–102.000) |  < 0.001 | 90.000 (84.000–96.000) | 74.000 (68.775–82.000) |  < 0.001 |
Weight (kg) | 78.000 (71.600–85.000) | 69.000 (62.80–76.000) |  < 0.001 | 65.100 (60.000–73.000) | 60.000 (55.000–66.000) |  < 0.001 |
Height (cm) | 170.000 (165.000–174.000) | 169.500 (165.00–174.00) |  < 0.001 | 158.000 (158.000–162.000) | 159.000 (155.000–163.500) |  < 0.001 |
TC (mg/dL) | 166.519 (107.174–247.678) | 99.203 (72.631–138.175) |  < 0.001 | 88.574 (67.316–120.461) | 150.576 (99.203–211.692) |  < 0.001 |
TG (mg/dL) | 199.923 (174.787–229.312) | 188.322 (165.120–214.230) |  < 0.001 | 208.817 (180.201–237.046) | 191.029 (167.440–217.324) |  < 0.001 |
HDL-C (mg/dL) | 46.790 (39.830–54.911) | 53.751 (46.404–63.032) |  < 0.001 | 52.591 (45.630–61.872) | 60.325 (52.978–69.606) |  < 0.001 |
LDL-C (mg/dL) | 123.163 (102.088–147.718) | 115.623 (96.674–135.731) |  < 0.001 | 125.677 (103.248–148.105) | 113.369 (93.194–133.411) |  < 0.001 |
FBG (mg/dL) | 109.800 (100.800–122.400) | 97.200 (91.800–109.800) |  < 0.001 | 108.000 (100.800–122.400) | 97.200 (91.800–106.200) |  < 0.001 |
SBP (mmHg) | 137.000 (128.000–149.000) | 126.000 (116.000–137.000) |  < 0.001 | 137.000 (125.000–151.000) | 97.200 (91.800–106.200) |  < 0.001 |
DBP (mmHg) | 89.000 (82.000–97.000) | 82.000 (75.000–90.000) |  < 0.001 | 85.000 (78.000–93.000) | 78.000 (72.000–86.000) |  < 0.001 |